Home

Barinthus Biotherapeutics plc - American Depositary Shares (BRNS)

1.0100
0.00 (0.00%)

Barinthus Biotherapeutics plc is a biopharmaceutical company focused on the discovery and development of innovative therapies aimed at treating a range of serious diseases

The company utilizes advanced biotechnological approaches to create novel drug candidates that target underlying mechanisms of illness. With a commitment to enhancing patient outcomes, Barinthus Biotherapeutics emphasizes research and development to deliver effective and safe treatments, advancing the field of medicine and addressing unmet medical needs.

SummaryNewsPress ReleasesChartHistoricalFAQ
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 13, 2024
BRNS Stock Earnings: Barinthus Biotherapeutics Misses EPS for Q2 2024investorplace.com
BRNS stock results show that Barinthus Biotherapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 8, 2024
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 21, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 5, 2024
Barinthus Biotherapeutics: Q4 Earnings Insightsbenzinga.com
Via Benzinga · March 20, 2024
BRNS Stock Earnings: Barinthus Biotherapeutics Beats EPS for Q1 2024investorplace.com
BRNS stock results show that Barinthus Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 13, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 1, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · April 30, 2024
Infection-Focused Barinthus Bio's VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectivesbenzinga.com
Explore the latest findings from Barinthus Biotherapeutics on VTP-200's performance in the APOLLO trial for low-grade cervical lesions linked to persistent hrHPV infection. Positive trends were noted, though not statistically significant. No major safety concerns were observed.
Via Benzinga · April 19, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · April 4, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · April 3, 2024
BRNS Stock Earnings: Barinthus Biotherapeutics Beats EPS for Q4 2023investorplace.com
BRNS stock results show that Barinthus Biotherapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 20, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · February 19, 2024